WINNIPEG, MANITOBA -- (MARKET WIRE) -- November 02, 2006 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular focused biopharmaceutical company, today announced its President and CEO, Albert D. Friesen, PhD, will present at Windhover Information’s Cardiovascular Alliances Conference at 2:30 PM Central Time on November 16, 2006 at the Hyatt Regency in Chicago, Illinois. Dr. Friesen will discuss Medicure’s cardioprotective compound, MC-1, which was selected by Windhover as one of the “Top 10 Licensable Cardiovascular Projects” available for partnering. The selection was made by an independent committee assembled by Windhover Information, a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries.
